GALT
GALECTIN THERAPEUTICS INC · Healthcare · Market cap $339.9M
Insiders sold $522K net in the last 90 days ·2 sellers, 0 buyers· 7 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 16, 2026
Insider Buying
$23K
reported purchases (SEC code P)
Insider Selling
$6.5M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Aug 4, 2026
Jamil Khurram
GALECTIN THERAPEUTICS INC (GALT) has 36 SEC Form 4 filings (130 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 4, 2026.
Inside the rolling window, 7 insiders at GALECTIN THERAPEUTICS INC reported 3 open-market purchases totaling $23K and 42 open-market sales totaling $6.5M. The most active filer is Chief Medical Officer Jamil Khurram with 11 filings. Insiders have net sold $521K over the trailing 6 months. The most recent open-market filing is a sale of 16,250 shares by Chief Medical Officer Jamil Khurram, dated Jul 14, 2026, worth $83K.
- Industry:Biotechnology
- CEO:Joel Lewis
- Employees:9
- HQ:Norcross, GA, US
- IPO:2002-09-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 16,250 | $83K | Jul 16 | -20.3% | SEC ↗ | |
Shlevin Harold H.First in 6 months | Director | Sale | 7,732 | $39K | Jun 30 | -27.4% | SEC ↗ |
Shlevin Harold H.First in 6 months | Director | Sale | 22,268 | $112K | Jun 30 | -27.4% | SEC ↗ |
| Chief Medical Officer | Sale | 4,570 | $23K | Jun 30 | -27.4% | SEC ↗ | |
| Chief Medical Officer | Sale | 47,467 | $239K | Jun 30 | -27.4% | SEC ↗ | |
| Chief Medical Officer | Sale | 7,557 | $24K | Jun 25 | -20.3% | SEC ↗ | |
Jamil KhurramFirst in 5 months | Chief Medical Officer | Sale | 568 | $2K | May 28 | +31.1% | SEC ↗ |
| Director | Purchase | 300 | $810 | Feb 9 | +23.9% | SEC ↗ | |
| Chief Financial Officer | Sale | 13,914 | $58K | Jan 6 | -2.3% | SEC ↗ | |
| Chief Financial Officer | Sale | 25,732 | $100K | Jan 6 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 20,354 | $75K | Jan 6 | — | SEC ↗ | |
| President and CEO | Sale | 18,571 | $78K | Jan 6 | — | SEC ↗ | |
| President and CEO | Sale | 27,731 | $108K | Jan 6 | — | SEC ↗ | |
| President and CEO | Sale | 37,698 | $135K | Jan 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 13,055 | $55K | Jan 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 25,499 | $99K | Jan 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 21,446 | $78K | Jan 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 8,125 | $33K | Jan 5 | — | SEC ↗ | |
FREEMAN KEVIN DFirst filing | Director | Purchase | 5,500 | $20K | Dec 23 | — | SEC ↗ |
ELDRED KARYFirst filing | Director | Purchase | 700 | $3K | Dec 23 | — | SEC ↗ |
| Chief Medical Officer | Sale | 19,442 | $137K | Dec 19 | — | SEC ↗ | |
| Director | Sale | 24,499 | $172K | Dec 19 | — | SEC ↗ | |
| President and CEO | Sale | 7,829 | $55K | Dec 19 | — | SEC ↗ | |
| 10% Owner | Sale | 30,681 | $204K | Dec 18 | — | SEC ↗ | |
| Director | Sale | 19,793 | $124K | Dec 16 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does GALT have?
GALECTIN THERAPEUTICS INC (GALT) has 36 SEC Form 4 filings (130 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Aug 4, 2026.
When was the most recent SEC Form 4 filing for GALT?
The most recent Form 4 filing for GALT on Tracefour is dated Aug 4, 2026.
Who is the most active insider at GALT?
The most active SEC Form 4 filer at GALT in the rolling window is Chief Medical Officer Jamil Khurram, with 11 filings.
What is the net insider flow at GALT over the last 6 months?
Over the trailing 180 days, insiders at GALT have net sold $521K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at GALT in the current window?
Inside the rolling window, insiders at GALT bought $23K and sold $6.5M based on SEC Form 4 filings.
Can I get alerts for GALT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at GALECTIN THERAPEUTICS INC (GALT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
GALECTIN THERAPEUTICS INC is in the Healthcare sector.